IP Library Granted Patent US 9,358,321
Granted Patent B2
US 9,358,321 · App. 14/385,658 · Granted Jun 7, 2016

Medical ceramic material and manufacturing method thereof

Inventors: Takefumi Nakanishi (Osaka, JP); Hironori Nagata (Osaka, JP)
Assignee: KYOCERA Medical Corporation
A61L27/105A61L27/045A61L27/10A61L27/425A61L27/427A61L27/50C04B35/10C04B35/119C04B35/64A61L2430/24C04B2235/3275C04B2235/602C04B2235/9646C04B2235/9661
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,321
App. No.
14/385,658
Granted
Jun 7, 2016
Kind
B2
Abstract

The present invention provides a medical ceramic material with a color other than black or white, especially blue, with which it is possible to secure sufficient durability and to maintain a good appearance by sufficiently suppressing a color difference between before and after the irradiation of gamma-rays for sterilization. The medical ceramic material is formed using a composite material containing alumina and zirconia. The composite material contains cobalt oxide. The content of cobalt oxide is set to be 0.2 wt % to 1.0 wt % with respect to 100 wt % of the composite material excluding cobalt oxide.

Claims (17)

1. A medical ceramic material formed using a composite material containing alumina and zirconia, wherein

the composite material contains cobalt oxide, and the cobalt oxide is greater than 0.2 wt % to 1.0 wt % with respect to 100 wt % of the composite material excluding the cobalt oxide,

the composite material further contains titanium dioxide and at least one of strontium oxide, silicon dioxide, and magnesium oxide;

the composite materials are composed of particles with an average particle diameter of the particles of 1.0 micron or less; and

a color difference (ΔE) measured in the medical ceramic is less than 3.5 after the medical ceramic undergoes gamma irradiation sterilization.

2. The medical ceramic material according to claim 1 ,

wherein the cobalt oxide is greater than 0.2 wt % and less than 0.5 wt %.

3. A method for manufacturing a medical ceramic material comprising:

a mixing step of mixing powders of at least alumina, zirconia, cobalt oxide, and titanium dioxide and at least one of strontium oxide, silicon dioxide, and magnesium oxide to form a mixed powder;

a pressing step of pressing the mixed powder to form a powder compact; and

a firing step of firing the powder compact to form a sintered body,

wherein the cobalt oxide contained in the mixed powder is greater than 0.2 wt % and less than 1.0 wt % with respect to 100 wt % of the mixed powder formed in the mixing step excluding the cobalt oxide,

wherein a color difference (ΔE) measured in the medical ceramic is less than 3.5 after the medical ceramic undergoes gamma irradiation sterilization

wherein an average particle diameter of the particles contained in the sintered body is 1.0 micron or less.

4. The method for manufacturing a medical ceramic material according to claim 3 ,

wherein the cobalt oxide in the mixing step includes tricobalt tetroxide.

5. The medical ceramic material of claim 1 , wherein the cobalt oxide includes tricobalt tetroxide.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Jun 15, 2026
From: KYOCERA CORPORATION
To: KYOCERA MEDICAL CORPORATION
Reel/Frame 074947/0956 →
CHANGE OF ADDRESS Recorded Jun 15, 2026
From: KYOCERA CORPORATION
To: KYOCERA CORPORATION
Reel/Frame 075981/0882 →
MERGER Recorded Dec 29, 2017
From: KYOCERA MEDICAL CORPORATION
To: KYOCERA CORPORATION
Reel/Frame 044504/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2014
From: NAKANISHI, TAKEFUMI; NAGATA, HIRONORI
To: KYOCERA MEDICAL CORPORATION
Reel/Frame 033751/0107 →
Priority Claims (1)
JP 2012-061025 · Mar 16, 2012 · national
Continuity (1)
Related Publication 20150038319A1 · Feb 5, 2015